Your browser doesn't support javascript.
loading
Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation.
Holland, Elizabeth M; Molina, John C; Dede, Kniya; Moyer, Daniel; Zhou, Ting; Yuan, Constance M; Wang, Hao-Wei; Stetler-Stevenson, Maryalice; Mackall, Crystal; Fry, Terry J; Panch, Sandhya; Highfill, Steven; Stroncek, David; Little, Lauren; Lee, Daniel W; Shalabi, Haneen; Yates, Bonnie; Shah, Nirali.
Afiliación
  • Holland EM; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Insitutes of Health, Bethesda, Maryland, USA.
  • Molina JC; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Insitutes of Health, Bethesda, Maryland, USA.
  • Dede K; Department of Pediatric Oncology, Johns Hopkins Hospital, Baltimore, Maryland, USA.
  • Moyer D; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Insitutes of Health, Bethesda, Maryland, USA.
  • Zhou T; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Yuan CM; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Wang HW; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Stetler-Stevenson M; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Mackall C; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Fry TJ; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Insitutes of Health, Bethesda, Maryland, USA.
  • Panch S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, California, USA.
  • Highfill S; Division of Hematology/Oncology/SCT and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, California, USA.
  • Stroncek D; Division of Stem Cell Transplant and Cell Therapy, Department of Medicine, Stanford, California, USA.
  • Little L; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Insitutes of Health, Bethesda, Maryland, USA.
  • Lee DW; University of Colorado Anschutz Medical Campus and Center for Cancer and Blood Disorders, Children's Hospital of Colorado, Aurora, Colorado, USA.
  • Shalabi H; Center for Cellular Engineering, Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
  • Yates B; Center for Cellular Engineering, Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
  • Shah N; Center for Cellular Engineering, Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
J Immunother Cancer ; 10(5)2022 05.
Article en En | MEDLINE | ID: mdl-35534047
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma de Células B / Leucemia-Linfoma Linfoblástico de Células Precursoras / Receptores Quiméricos de Antígenos Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma de Células B / Leucemia-Linfoma Linfoblástico de Células Precursoras / Receptores Quiméricos de Antígenos Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article